In patients with chronic kidney disease (CKD), how does the use of sodium-glucose cotransporter-2 (SGLT2) inhibitors, compared to standard care, impact the progression of renal function decline?: A Systematic Review. (pp.89-99)
BY-Pooja Prakash Rathod, Kirti Patle.- Volume 1 Issue 1 (May-Aug) 2024, Article 10 (pp.89-99) Key Points Question: In patients with chronic kidney disease (CKD), how does the use of sodium-glucose…